Page last updated: 2024-10-21

1-anilino-8-naphthalenesulfonate and Angina Pectoris with Normal Coronary Arteriogram

1-anilino-8-naphthalenesulfonate has been researched along with Angina Pectoris with Normal Coronary Arteriogram in 2 studies

1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.

Research Excerpts

ExcerptRelevanceReference
"This study describes the changes in risk factors for coronary heart disease in obese persons with syndrome X after orlistat-assisted weight loss."9.09Effect of orlistat-assisted weight loss in decreasing coronary heart disease risk in patients with syndrome X. ( Boldrin, M; Hauptman, J; Lucas, C; Reaven, G; Segal, K, 2001)
"This study describes the changes in risk factors for coronary heart disease in obese persons with syndrome X after orlistat-assisted weight loss."5.09Effect of orlistat-assisted weight loss in decreasing coronary heart disease risk in patients with syndrome X. ( Boldrin, M; Hauptman, J; Lucas, C; Reaven, G; Segal, K, 2001)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Reaven, G1
Segal, K1
Hauptman, J1
Boldrin, M1
Lucas, C1
Jansen, H1
Waterworth, DM1
Nicaud, V1
Ehnholm, C1
Talmud, PJ1

Trials

1 trial available for 1-anilino-8-naphthalenesulfonate and Angina Pectoris with Normal Coronary Arteriogram

ArticleYear
Effect of orlistat-assisted weight loss in decreasing coronary heart disease risk in patients with syndrome X.
    The American journal of cardiology, 2001, Apr-01, Volume: 87, Issue:7

    Topics: Adult; Anti-Obesity Agents; Cholesterol, HDL; Diet, Reducing; Double-Blind Method; Female; Humans; I

2001

Other Studies

1 other study available for 1-anilino-8-naphthalenesulfonate and Angina Pectoris with Normal Coronary Arteriogram

ArticleYear
Interaction of the common apolipoprotein C-III (APOC3 -482C > T) and hepatic lipase (LIPC -514C > T) promoter variants affects glucose tolerance in young adults. European Atherosclerosis Research Study II (EARS-II).
    Annals of human genetics, 2001, Volume: 65, Issue:Pt 3

    Topics: Adult; Alleles; Apolipoprotein C-III; Apolipoproteins C; Arteriosclerosis; Blood Glucose; Blood Pres

2001